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Abstract 
This investigation explored the role of PKC as an activator ofVRl through the use of capsaicin, a 
natural ligand for VRl, and the PKC activating phorbol ester 12,13 dibutyrate (PDBu). Direct effects of 
30nM, 300nM, and 3000nM capsaicin and OnM, 0.3nM, 1.0nM, 3.0nrn, lOnM, and 30nM PDBu on 
glutamate release from adult rat dorsal root ganglia (DRGs) were examined. Based on those observations, 
the concentration of capsaicin causing the least glutamate release and the concentrations of PD Bu that did 
not elicit significant glutamate release were selected to study effects of capsaicin on same cell type acutely 
sensitized with the selected concentrations of PD Bu. It was found that glutamate released from 
combinations of30nM capsaicin and 1.0nM PDBu (p<0.036) as well as 30nM capsaicin and 3.0nM PDBu 
(p<0.01) were statistically significant from the stimulation control-which was 30nM capsaicin alone. 
Introduction 
Because they activate protein kinase C (PKC) in vitro (Parker 1998), phorbol esters are often used 
to investigate PKC function in cells. PKC refers to a family of eleven serine-threonine kinase isoforms 
with unique substrate specificities and roles in cell regulation and differentiation (Blobe et al. 1996). For 
instance, PKC is known to translocate from the cytosol to the plasma membrane for activation by 
diacylglycerol (DAG), an endogenous substrate. Phorbol esters compete with DAG for its binding site on 
PKC. It has been demonstrated that the C 1 domains of classical and novel PKC isoforms bind 
diacylglycerol and phorbol esters with high affinity, after acute (10 minutes) exposure to phorbol esters 
(Wang et al. 2001). Chronic exposure (24-48 hours) leads to PKC isotype selective proteolysis and down-
regulation (Kramer & Simon 1999). 
Small diameter peripheral neurons, A8 and C-fibers, have been recognized as the peripheral nerve 
types carrying protopathic information-pain, temperature, and crude touch. When introduced into the 
body, capsaicin, an exogenous substance found in chili peppers, specifically binds vanilloid receptors of 
type 1 (VRl), which are expressed in A8 and C-fibers (Huang 2002). VRl is involved in transmitting 
noxious chemical and heat stimuli from the periphery to the central nervous system. One direct role of 
PKC in VRl activation has been recently proposed. PKC-a was required for acute activation ofVRl with 
phorbol 12, 13 dibutyrate, (PDBu), a small and somewhat hydrophilic phorbol ester, in embryonic dorsal 
root ganglia (DRG) cells and in NIH 3T3 and HeLa cells transfected to express a VRl (Olah et al. 2002). 
Demonstrating that PD Bu is capable of enhancing resting and capsaicin-stimulated glutamate 
release in adult rat sensory neurons lends further insight into the mechanism of PKC-induced neuron 
sensitization in human pain transmission and perception. PDBu has been shown to enhance resting and 
capsaicin-stimulated calcitonin gene-related peptide (CGRP) and substance P (SP) release in embryonic rat 
DRG (Barber & Vasco, 1996). 
Although glutamate and its receptors have been recognized as important in the neurotransmission 
of acute pain and the onset of chronic pain (Varney & Gereau 2002), there has not been extensive study of 
the regulation of glutamate release from sensory neurons. It is known that glutamate is stored in synaptic 
vesicles at nerve terminals and is immediately released upon sensory neuron stimulation. However, a direct 
connection between PKC and VRl activation and known mechanisms of glutamate release has not been 
established. 
Since the adult rat peripheral nervous system (PNS) is without the developmental consideration 
present in an embryonic model, DRG cells of adult rats were used. By virtue of PD Bu activity as a PKC 
agonist, it was hypothesized that capsaicin stimulation of glutamate release would be enhanced by PDBu. 
It was found that treating the cultured cells with increasing capsaicin or PDBu elicited a concentration-
dependent increase in glutamate release. Given alone, 30nM capsaicin and 0.3nM, 1.0nM, and 3.0nM 
PDBu did not induce glutamate release from cultured DRG cells. However, treating the cells with 30nM 
capsaicin after acute sensitization with 1.0nM or 3.0nM PDBu caused significantly higher glutamate 
release than treatment with 30nM capsaicin alone. 
Additionally, this study utilizes a novel paradigm, developed by Dr. Judith Richter in the 
Pharmacology and Toxicology department at Indiana University-Purdue University at Indianapolis, for the 
assay of glutamate released in low concentrations from adult rat DRG cells in culture. 
Materials and Methods 
Materials 
Forty to forty-five-day-old, male Sprague-Dawley rats were purchased from Harlan-Sprague 
Dawley (Indianapolis, IN, U.S.A.). Costar twenty-four well culture plates were bought from Fisher 
Scientific (Chicago, IL, U.S.A.). Other cell culture supplies were procured from lnvitrogen/Gibco 
(Carlsbad, CA, U.S.A.). Nerve growth factor was acquired from Harlan Bioproducts for Science 
(Indianapolis, IN, U.S.A.). 
Phorbol 12,13,-dibutyrate (PDBu) and 8-methyl-n-vanillyl-6-nonenamide (Capsaicin) were 
obtained from Sigma Chemical Company (St. Louis, MO, U.S.A.). 
Dibasic sodium phosphate was from Mallinckrodt Baker (Phillipsburg, NJ, U.S.A.), and 
chromatographic grade o-pthalaldehyde (OPA) and OPA diluent were acquired from Pickering 
Laboratories (Mountain View, CA, U.S.A.). Millipore Ultrafree Biomax centrifugation filters (lOK cutoff) 
with tubes and Optima Grade Methanol were bought from Fisher Scientific (Chicago, IL, U.S.A.). All 
other chemicals were obtained from Sigma/Aldrich/Fluka (St. Louis, MO, U.S.A.) . 
Capsaicin and phorbol ester were initially dissolved in l-methyl-2-pyrrolidinone (MPL) and 
diluted to appropriate concentrations with AB buffer (explained below) for release experiments. Resultant 
solutions contained MPL concentrations of0.03% or less, which affected neither neurotransmitter release 
nor the assay of glutamate (glu) or calcitonin gene related peptide (CGRP). 
The procedures used in this exercise were approved by the Animal Care and Use Committee at 
Indiana University School of Medicine (Indianapolis, IN, U.S.A.). 
Maintaining sensory neurons in culture 
Sensory neurons were harvested and cultured according to standard procedures (Southhall & 
Vasco, 2001 ), with a few modifications. In detail, the following procedure was used. 
Adult rats were first euthanized in a syrofoam C02 chamber. Their vertebral columns, from the 
upper brainstem to the cauda equina, were manually removed. Spinal cords were ejected from the columns 
by forcing sterilized Puck's solution into the caudal end of the columns with a syringe. The columns were 
then placed in HEPES buffer, containing 25nM HEPES, 135mM NaCl, 3.5mM KC!, 2.5mM CaCl2, lmM 
MgC12, 3.3mM D-glucose, O.OOlmM phosphoramidon and 0.1 % bovine serum albumin at pH 7.4 and 
37°C, which was supplemented with 1.6µg/ml Fungizone® to inhibit fungal contamination in the 
remainder of the preparation. 
The columns were removed from the supplemented buffer, and Mid-line cuts along the length of 
the dorsal and ventral surfaces of the columns were then made to reveal the DRGs in their recesses. Using 
a Nikon model SMZ645 light microscope at 8 times magnification, the DRGs were mechanically extracted 
from their recesses and collected in a culture dish filled with sterilized Puck's solution on ice. In the culture 
dish the DRG afferent and efferent nerve processes were removed with a scalpel. 
Trimmed DRGs were then incubated in a culture dish with 3 mL ofF-12 media containing 1 mg 
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collagenase IA for two hours at 37 °C, in two separate intervals. After the two hour incubation, the 
DRGs and incubation fluid were transferred to a 20mL conical tube, in a sterile atmosphere. Following one 
minute centrifugation, the enzymatic supernatant removed. The cellular pellet was re-suspended in F-12 
medium supplemented with 250 ng mr1 7S-nerve growth factor and 50mg/ml Normocin 0™. Cells were 
then mechanically dissociated from the DRGs using fire polished Pasteur pipettes until a uniform 
suspension remained. Approximately 22,500 cells per well were plated onto 24-well, polystyrene culture 
plates, formerly coated with poly-D-lysine and laminin. The cells were maintained in an atmosphere of3% 
C02/97% air at 37°C for nine days. The incubation medium containing F-12 with nerve growth factor and 
Normocin O™ was exchanged, on the second (48h), third (72h), sixth (144h), and eighth (192h) days after 
plating. Release studies were performed on the ninth day. 
Glu release experiments from sensory neurons in culture 
Sensory neurons were washed, within their culture wells, three times with HEPES buffer. After 
washing, 0.5mL of buffer was added to each well and the cultures incubated for one hour at 37°C. The 
cells were again washed three times with HEPES buffer. At this point, buffer with or without added drugs 
was applied in 0.5 mL aliquots and incubated for 10 minutes at 37°C, and four or more such incubations 
were performed. Generally, a control (basal) incubation was followed by a second, ten-minute incubation 
in HEP ES buffer or HEP ES buffer containing various concentrations of PD Bu. Subsequently, cells were 
incubated for a third ten-minute interval in HEPES buffer containing various capsaicin and, or, PDBu 
concentrations, often in combinations, to stimulate glu release under a sensitized state. Cells were then 
incubated for a final ten-minute interval in HEPES buffer without stimulating agents. 
Assay of glutamate released from sensory neurons 
This procedure was performed according to Richter et al. (in preparation). Specifically, 20µL of 
IM perchloric acid containing 12.5µM homoserine, an internal standard, was added to 200µL of the 
second, third, and fourth groups of buffers collected from experimentation. Homoserine in perchloric acid 
was also added to 200µL aliquots of a set of glutamate standards (0, 5, 10, 20, and 40 pmoles glu/20 µL). 
The solutions were mixed, transferred to centrifugation filters, and centrifuged at 1 O,OOOg for 
approximately 15 minutes at 4 °C. 
20µL of the filtrate in autosampler tubes were then placed into an autosampler at 4°C. There, 
15 µL of daily prepared derivative forming reagent, made by a four-fold dilution of a weekly prepared stock 
solution (27mg o-Phthaldialdehyde (OPA), 7.5µL [3-mercaptoethanol, lmL methanol and 9mL OPA 
diluent) in OPA diluent, was injected into one sample. One minute later, 27µL of the sample/reagent 
mixture was automatically injected onto a reverse phase, 3 micron, 4.6 mm x 8 cm, C-18 column (model 
HR-80 from ESA, Inc., Chelmsford, MA, U.S.A.). Solvent composition remained constant throughout 
analysis with a mobile phase of O. lM sodium phosphate at pH 6. 75 with 24% methanol pumped at 
l.2mL/min. 
Amino acids were electrochemically detected by a dual electrode ESA Coulochem II system. 
First, an electrochemical cell oxidized impurities in the sample at 300mV. A second cell oxidized the 
remaining amino acid derivatives at 600mV. 
ESA System software, installed on an HP Pentium IV computer, generated chromatographs and 
standard curves for experiment samples. Glutamate and homoserine eluted at approximately three and ten 
minutes respectively. Furthermore, ESA software calculated experimental glutamate concentrations within 
a sample, based upon homoserine levels and the glutamate standard curve. 
Statistical Analysis 
Data are presented as mean± SEM. Values more than two times the standard deviation away 
from the mean were excluded. Each set of experiments was repeated using two or more different culture 
preparations to account for variability among different cultures. One-way ANOV A tests, with Dunnett or 
Bonferoni post hoc tests, comparing basal release to stimulated release in direct effect studies of capsaicin 
and PDBu, were performed with Graph Pad Prism software (San Diego, CA). A one-way ANOV A and 
LSD post hoc test was performed on transformed data, using Statistica software (Statsoft, Inc., Tulsa, OK, 
U.S.A.), for analysis of combined PDBu and capsaicin stimulation studies. In all cases significance was 
set at p:S0.05. 
Data and Results 
To study the direct, concentration-related effects of capsaicin on glutamate release, culture wells 
were incubated in 0.5mL HEPES buffer containing 30nM, 300nM, or 3000nM capsaicin for 10 minutes at 
37°C. This followed two ten-minute incubations in 0.5mL of buffer alone. Cells were then incubated a 
final 0.5mL of buffer for ten minutes. Incubation fluid was collected at the end of each interval. 
Glutamate assayed from the second, third, and fourth collections demonstrated a concentration-
dependent relationship between the increasing capsaicin concentrations applied and resultant glutamate 
release, as indicated (Figure 1.) A one-way ANOV A on the capsaicin stimulation results using GraphPad 
Prism showed a significant effect of capsaicin concentration (p<0.0072). There was an approximate 50% 
increase in the stimulated glutamate release with exponential increases in the given capsaicin 
concentrations. Because it stimulated the least glutamate release and no apparent increase over basal 
glutamate release, 30nM capsaicin was chosen to stimulate glutamate release in the final sensitization, or 
combined experiments. 
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Culture wells were incubated for four ten-minute intervals in solutions of HEPES buffer, HEPES buffer (Basal), HEP ES buffer containing the 
indicated capsaicin concentrations, or HEPES buffer (Return to Basal), successively. Glutamate released into buffer was assayed as described in 
Methods and Materials and is expressed as pmoles of glutamate per well. The second, third, and fourth collections were assayed. These values 
depicted as means ± SEM, n=S-6. 
In evaluating the direct concentration effect of PD Bu on glutamate release, culture wells were 
incubated in 0.5mL HEPES buffer containing OnM, 0.3nM, l.OnM, 3.0nM, lOnM, or 30nM PDBu in three 
successive ten minute intervals at 37°C, following one ten-minute incubation in 0.5mL of buffer alone. 
Again, incubation fluids were collected at the end of each ten-minute incubation interval. Glutamate 
released from the second third and fourth intervals are represented in Table 1. 
Table I. Amount of f!lutamate releasedfrom direct PDBu treatment 
Duration of Control 0.3nM PDBu 1.0nMPDBu 3.0nM PDBu lOnMPDBu 30nMPDBu 
treatment (pm oles/well) (pm oles/well) (pm oles/well) (pm oles/well) (pm oles/well) (pm oles/well) 
10 minutes 113.963 ± 337.466 ± 201.720 ± 332.841 ± 211.613± 281.423 ± 
19.933 213.435 29.330 157.645 22.809 37.664 
20 minutes 157.758 ± 175.506 ± 175.671± 235.673 ± 290.153± 254.946 ± 
60.933 75.906 15.317 47.603 23.537 37.481 
30 minutes 161.090 ± 117.384± 253.629 ± 189.267 ± 265.971 ± 239.033 ± 
52.888 27.517 121.817 51.648 33.887 32.373 
Culture wells were incubated for four ten-minute intervals in solutions of HEPES buffer, followed by three applications of HEPES buffer 
containing the indicated PDBu concentrations, successively. Glutamate released into buffer was collected and assayed after each interval as 
described in Methods and Materials. The second, third, and fourth collections, containing glutamate released after 10, 20, and 30 minute 
durations of PDBu treatment, were assayed. The values indicated are means± SEM, n=6-7. 
A two-way ANOV A on the glutamate measurements in Table 1, using GraphPad Prism, indicated 
significance (p<0.05) with respect to PDBu concentration (p<0.0001) and no significance with respect to 
time (p<0.608). Based on this, the glutamate measurements were collapsed with respect to time and a one-
way ANOV A with Dunnets's post hoc Multiple Comparison Test was performed with the concentration of 
PDBu as variable. These results show that lOnM and 30nM PDBu caused significant (p<0.001 for both 
concentrations) glutamate release from the adult DRG cells. This result is depicted in Figure 2. Since 
0.3nM, l.OnM, and 3.0nM PDBu did not stimulate significant glutamate release, these concentrations were 
selected for "sensitizing" the cells in the final aspect of this study. 
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Figure 2. Amount of glutamate released from time collapsed direct PD Bu effects 
Time effects were not deemed significant in a two-way ANOV A of the data in Table 1, treating PD Bu concentration and time as variable. Thus, 
the data was collapsed with respect to time and analyzed in a one-way ANOV A and Dunnets's Multiple Comparison Test, with PDBu 
concentration as variable. This process indicated significant glutamate release due to treatment with IOnM (p<0.0001) or 30nM (p<0.0001) 
PD Bu;* indicates capsaicin-stimulated release significantly different from the OnM PDBu control. 
To investigate the combined effects of PD Bu sensitization and capsaicin stimulation, the 
concentrations of PD Bu that did not stimulate glutamate release alone and the capsaicin concentration 
causing the least amount of glutamate release, were identified from the previous experiments. Thus, 
culture wells were incubated in HEPES buffer; HEPES buffer containing OnM, 0.3nM, l.OnM, or 3.0nM 
PDBu; HEPES buffer containing 30nM capsaicin and OnM, 0.3nM, l.OnM, or 3.0nM PDBu; and then 
HEPES buffer with no stimulants in four IO-minute intervals at 37°C, successively. Incubation fluid was 
collected at the end of each interval. Glutamate released from the second third and fourth intervals are 
represented as Figure 3. 
750 
1 
::::J 500 
C'> 
(/) 
~ 
0 E 250 
a. 
0 
Effects of 0.3, 1.0, and 3.0nM PDBu on 
30nM capsaicin stimulated glutamate 
release from adult rat DRG cells 
PD Bu 
* 
* 
Stirn 
[PDBU] 
Basal 
Control 
llm0.3nM PDBu 
-1.0nM PDBu 
-3.0nM PDBu 
Figure 3. Amount of Glutamate Released from combined capsaicin and PD Bu treatment 
Culture wells were incubated for four ten-minute intervals in solutions of HEPES buffer, HEPES buffer with OnM, 0.3nM, 1.0nM, or 3.0nM 
PDBu (PD Bu); HEPES buffer with 30nM capsaicin and OnM, 0.3nM, t.OnM, or 3.0nM PDBu (Stirn); and HEPES buffer (Basal), successively. 
Solutions were collected after each interval as described in Methods and Materials. The second, third, and fourth collections were assayed and 
are expressed as pmoles of glutamate per well. Values are depicted as means± SEM, n=6-7; *indicates glutamate release significantly 
different from the 30nM capsaicin with OnM PDBu stimulation control. 
Using Stat Soft Statistica, the data depicted in Figure 3 was transformed to eliminate correlations 
between the means and SEM. Then, a one-way ANOV A followed by the LSD post hoc test was performed 
on the results from the stimulation interval only. This process indicated that glutamate released from 
combinations of30nM capsaicin and l.OnM PDBu (p<0.036) as well as 30nM capsaicin and 3.0nM PDBu 
(p<0.01) were statistically significant from the stimulation control-which was HEPES buffer with 30nM 
capsaicin alone. 
A comparison of absolute glutamate released from the culture wells incubated in buffer with 
capsaicin, PDBu, and combined capsaicin and PDBu lends an additional interpretation. On average the 
22,500 cells in each well released 178.41 ± 54.5 pmoles of glutamate when incubated in buffer with 30nM 
capsaicin only. The wells incubated in buffer with l.OnM PDBu and buffer with 3.0nM PDBu released 
210.29 ± 55.4 and 252.59 ± 85.6 pmoles of glutamate per well on average, respectively. In the combined 
treatments, wells incubated with buffer and 30nM capsaicin and l .OnM PDBu released 379.31 ± 56.1 
pmoles of glutamate per well and those incubated in buffer and 30nM capsaicin and 3.0nM PDBu released 
456.49 ± 93.0 pmoles of glutamate per well. Compared to wells incubated with buffer and respective 
concentrations of PD Bu alone, wells incubated in buffer with combined capsaicin and l.OnM or 3.0nM 
PDBu released 80.4 ± 26.5% or 80.7 ± 35.5% more glutamate. Furthermore, the wells incubated in buffer 
and 30nM capsaicin and l.OnMPDBu and 30nM capsaicin and 3.0nM PDBu released 112.6 ± 31 % and 
155.9 ± 41.3% greater glutamate than cells incubated in buffer and 30nM capsaicin alone. 
Discussion 
The scope of this experiment posits that combined PD Bu and capsaicin are capable of stimulating 
greater glutamate release than either substance would elicit alone. This observation is particularly 
supported by the effects of cells sensitized with l.OnM or 3.0nM PDBu and stimulated with 30nM 
capsaicin. 
Significant increases in glutamate release due combined effects, or sensitization, in this study add 
further perspective to the question of the mechanism of PKC and VRl interaction. These acute findings 
support a hypothetical mechanism whereby PDBu diffuses across the plasma membrane, allowing PDBu to 
activate PKC. Furthermore, activated PKC could enhance VRl directly, rendering VRl more sensitive to 
capsaicin. Verifying PDBu's action as a PKC activator in this result necessitates further study in this 
experimental model. In addition to utilizing a diffusible PKC inhibitor with PDBu and capsaicin in buffer, 
observing the results of a non-PKC-activating, diffusible phorbol would help identify PDBu function. A 
decline in glutamate release, when using the PKC inhibitor, would support the finding that PKC enhances 
the VRl response to capsaicin. Analogously, decreased glutamate release with the non-PKC-activating 
phorbol would support the observation that PDBu acutely sensitizes the cell, via PKC activation, to 
enhance glutamate release-as proposed in this study. 
This experiment was designed to identify concentrations of capsaicin and PDBu that gave no 
stimulation and to observe the combined effects of those concentrations in buffer rather than test higher 
concentrations. In acknowledging that capsaicin stimulatory effects reach a maximum (Richter, 
unpublished observations) and appreciating the possibility that PDBu stimulation might also have a ceiling, 
it was reasoned that any combined effect would be more clearly apparent in the current milieu. 
Furthermore, the need to eliminate any undesirable effects of PD Bu at higher concentrations, beyond its 
recognized role as a PKC agonist, was made less likely. 
An unexpected phenomenon occurred in testing the direct effects of PD Bu and in the combined 
studies. Namely, the glutamate released from wells incubated in buffer with 0.3nM PDBu was consistently 
depressed, relative to the glutamate released from buffer containing neither capsaicin, nor PDBu. This 
phenomenon may be the reason why the combination of buffer with 30nM capsaicin and 0.3nM PDBu did 
not produce statistically significant results. It has been demonstrated that phorbol derivatives have been 
capable of activating TRPV 4, a heat sensitive ion channel belonging to the same family as VRl (TRPV 1) 
(Guler et al. 2002). Considering that the HEPES buffer in this experiment is kept on ice and heated, 
possibly not to 37°C as intended, begs the question of whether or not VRl is also sensitive to temperature. 
One can also appreciate that glutamate is rapidly cleared from the synaptic cleft by cellular re-
uptake mechanisms. This too may have a significant effect in determining the actual amount of glutamate 
released due to stimulation. Thus, it would beneficial to observe the combined PDBu and capsaicin 
experiments in the presence of a glutamate re-uptake inhibitor, such as P-threo-benzyloxy-aspartate 
(Richter, unpublished observations). 
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